Certain type of implanted lenses may be a treatment option for some patients with nearsightedness

July 13, 2009

CHICAGO - Implantable lenses made of a collagen-like substance appear to provide stable correction of moderate to high nearsightedness (myopia) over four years of follow-up, according to a report in the July issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

"Laser-assisted in-situ keratomileusis (LASIK) has gained widespread popularity as a safe and effective surgical method for the correction of myopia, but patients with high [severe] myopia or thin corneas face some restrictions in avoiding the risk of developing keratectasia [a weakening of the cornea]," the authors write as background information in the article.

An implantable lens consisting of a biocompatible collagen copolymer was developed to overcome these disadvantages, and has been reportedly effective in correcting moderate to severe vision problems. The implantation procedure is largely reversible and the lens is interchangeable, unlike LASIK. However, complications such as the formation of cataracts, loss of cells lining the eye and glaucoma have been reported and are expected to increase with time.

To assess the long-term clinical outcomes of the lens implantation, Kazutaka Kamiya, M.D., Ph.D., of the University of Kitasato School of Medicine, Kanagawa, Japan, and colleagues evaluated 56 eyes of 34 patients who underwent implantation of the collagen copolymer lens. Routine post-operative examinations were conducted one, three and six months and one, two and four years later.

At four years after surgery, 44 of the eyes (79 percent) were within 0.5 diopter (unit of measuring lens power) of the targeted correction and 52 (93 percent) were within one diopter. The authors suggest that collagen polymer lens implantation "results were good in all measures of safety, efficacy, predictability and stability for the correction of high myopia throughout the four-year follow-up," they write. "To our knowledge, this is the longest study to assess the refractive outcomes and adverse events" of the collagen copolymer lens implantation for myopia.

"In addition, no vision-threatening complications occurred throughout the follow-up period," they conclude. The authors note that their findings suggest that collagen copolymer lens implantation "may be a good alternative for the treatment of moderate to high myopia. More prolonged careful observation for longer than four years is necessary to assess late-onset complications of this surgical technique."
(Arch Ophthalmol. 2009;127[7]:845-850. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: Co-author Dr. Shimizu reported having been a consultant to STAAR Surgical Company. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

For more information, contact JAMA/Archives Media Relations at 312/464-JAMA (5262) or e-mail mediarelations@jama-archives.org.

The JAMA Network Journals

Related Myopia Articles from Brightsurf:

Six-Year MiSight contact lens study: 23% of eyes showed no additional myopia progression
The latest findings from the long-running CooperVision MiSight 1 day clinical study provide new insights about myopia management and the proven efficacy of the specially designed contact lens.

Multifocal contact lenses slow myopia progression in children
Children wearing multifocal contact lenses had slower progression of their myopia, according to results from a clinical trial funded by the National Eye Institute, part of the National Institutes of Health.

Young nearsighted kids benefit from bifocal contact lenses, study shows
Bifocal contact lenses aren't just for aging eyes anymore. In nearsighted kids as young as 7 years old, multifocal contact lenses with a heavy dose of added reading power can dramatically slow further progression of myopia, new research has found.

New paper helps advance myopia management strategies
'Myopia Control 2020: Where are we and where are we heading?' has been published in Ophthalmic & Physiological Optics, the peer-reviewed journal of The College of Optometrists, giving eye care practitioners a comprehensive analysis of evidence-based information needed to help manage myopia.

Genetic processes that determine short-sightedness discovered by researchers
Three previously unknown genetic mechanisms have been discovered in causing myopia otherwise known as short or near-sightedness, finds a new study.

Faster, cheaper tests for myopia possible
The world's most common vision problem myopia or short/near sightedness, which causes damage to the eye and even blindness, just got easier to assess.

New approach to slowing nearsightedness in children shows promise
Combining 2 different treatment methods to slow the progression of myopia may deliver better results than either can achieve on their own.

Bright lights outdoors may help treat lazy eye in children
Amblyopia, also known as lazy eye, is a loss of vision that affects two to five percent of children across the world and originates from a deficit in visual cortical circuitry.

US $244 billion lost annually because people don't have spectacles to correct myopia
Vision impairment caused by uncorrected myopia cost the global economy an estimated US$244 billion in lost productivity in 2015, according to a new study published in the scientific journal Ophthalmology.

Study shows how light therapy might help premature babies avoid vision problems
Scientists discovered a light-dependent molecular pathway that regulates how blood vessels develop in the eye.

Read More: Myopia News and Myopia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.